Skip to main content
BBNX filings

Corporate insider profile

Mark Hopman Filing Activity

Latest reported as Chief Commercial Officer of Beta Bionics, Inc. (BBNX).

Purchase filings
0
Reported companies
1
Net open-market value
-$89,448.93
Latest transaction
Jun 24, 2026

Affiliated corporations

Reported company relationships

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Jun 24, 2026Beta Bionics, Inc. (BBNX)Chief Commercial OfficerSale1,258$15.01$18,880
Jun 4, 2026Beta Bionics, Inc. (BBNX)Chief Commercial OfficerSale275$12.31$3,385
Jun 2, 2026Beta Bionics, Inc. (BBNX)Chief Commercial OfficerSale5,329$12.61$67,183